U.S. Army Medical Research Acquisition Activity
Marylandhealth.mil
Overview
U.S. Army Medical Research Acquisition Activity is a United States government entity that serves as the contracting and assistance agreement arm of the U.S. Army Medical Research and Development Command, providing funding for medical research and development through contracts and grants.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Gateway Biotechnology, Inc. | Sep 2023 | Grant | Co-investor |
| HDT Bio Corp. | Aug 2022 | Grant | Co-investor |
| Sylvatica Biotech Inc. | May 2021 | Grant | Co-investor |
| RxFunction | Sep 2020 | Grant | Co-investor |
| Cellphire Therapeutics | Jan 2020 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
